| Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2 SK Dey, M Saini, C Dhembla, S Bhatt, AS Rajesh, V Anand, HK Das, ... Journal of Biomolecular Structure and Dynamics 40 (24), 14067-14083, 2022 | 13 | 2022 |
| Suramin, Penciclovir and Anidulafungin bind nsp12, which governs the RNA-dependent-RNA polymerase activity of SARS-CoV-2, with higher interaction energy than Remdesivir … SK Dey, M Saini, C Dhembla, S Bhatt, AS Rajesh, V Anand, S Kundu OSF Preprints 10, 2020 | 13 | 2020 |
| Red blood cells as therapeutic target to treat sickle cell disease S Bhatt, DA Argueta, K Gupta, S Kundu Antioxidants & Redox Signaling, 2024 | 1 | 2024 |
| A novel single sensor hemoglobin domain from the thermophilic cyanobacteria Thermosynechococcus elongatus BP-1 exhibits higher pH but lower thermal stability compared to … S Mathur, SK Yadav, K Yadav, S Bhatt, S Kundu International Journal of Biological Macromolecules 240, 124471, 2023 | 1 | 2023 |
| Sickle cell patients showed dysregulated plasma Rb/K ratio and Gamma-glutamyl cycle in red blood cells S Bhatt, AK Mohapatra, S Meher, AS Rajesh, PK Panda, R NANDA, ... | | 2023 |
| P-101: REMEDIAL EFFECT OF GUDUCHI SATWA IN SICKLE RED BLOOD CELLS–AN AYURVEDIC APPROACH A RAJESH, S BHATT, S MEHER, D MAJHI, S PANDA, S KUNDU, ... HemaSphere 6, 61, 2022 | | 2022 |
| P-092: RED BLOOD CELL GLUCOSE CONSUMPTION AND METABOLISM IN SICKLE CELL DISEASE A RAJESH, S MEHER, S BHATT, P PANDA, S KUNDU, B DASH HemaSphere 6, 59, 2022 | | 2022 |
| EVALUATION OF SAFETY AND EFFICACY OF HBS-SAILIN®: A POTENT INGENIOUS ANTI-SICKLING AGENT THAT REDUCES PAIN AND IMPROVES THE QUALITY OF LIFE IN SICKLE CELL PATIENTS. S Bhatt, AS Rajesh, A Bhansali, B Nwohgoh, S Meher, PK Panda, ... HemaSphere 6, 57-58, 2022 | | 2022 |
| P-088 MELIOIDOSIS AND SICKLE CELL DISEASE: DESCRIPTION OF A RARE ASSOCIATION YA PONGOMBO S., OKITOTSHO W., MUEPU T. S BHATT, A RAJESH, A BHANSALI, N BENEDICT, S MEHER, P PANDA, ... | | |
